| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 699490 | Doxoform | 0.0438391811600418 | 0.47636936 |
| NSC 704783 | Null | 0.0438391811600418 | 0.3587617 |
| NSC 705149 | Null | 0.0438391811600418 | 0.54045755 |
| NSC 707700 | Null | 0.0438391811600418 | 0.16061905 |
| NSC 708048 | 2-Butenoic acid, 4,4-dicyano-4-[[(3-thienyl)methylene]amino]-, ethyl ester, (2Z,1E)- | 0.0438391811600418 | 0.79930687 |
| NSC 709362 | Acetamide, N,N'-(1,5-pentanediyl)bis[2-(1,3,5,11a-tetrahydro- 5-oxopyrrolo[2,1-c][1,4]benzodiazepin-2-ylidene)- | 0.0438391811600418 | 0.71754329 |
| NSC 719162 | 11-(5'-Bromopentylidine)-5,6-dihydro-2,3-dimethoxy-6-methyl-8,9-methylenedioxy-5-oxo-11H-indeno[1,2-c]isoquinoline | 0.0438391811600418 | 0.40329164 |
| NSC 719376 | Null | 0.0438391811600418 | 0.39093589 |
| NSC 720177 | Null | 0.0438391811600418 | 0.51717627 |
| NSC 724062 | (2,3,4-trihydroxy-benzylidene-hydrazinocarbonylmethylsulfany l)acetic acid (2,3,4-trihydroxy-benzylidene)hydrazide | 0.0438391811600418 | 0.40123674 |